Ibuprofen in paediatrics: pharmacology, prescribing and controversies

Camilla Moriarty1, Will Carroll2

  • 1Department of Paediatric, Chelsea and Westminster Hospital, London, UK.

Insights

Ibuprofen is a common non-steroidal anti-inflammatory drug for children, but its use for fever is debated. Combined use with paracetamol is generally not recommended.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Safety

Background:

  • Ibuprofen, a propionic acid derivative, is a widely used non-steroidal anti-inflammatory drug (NSAID) in pediatric practice.
  • It is one of the most frequently prescribed medications for children in hospital settings, second only to paracetamol.
  • The use of antipyretics like ibuprofen for treating fever in children is a subject of ongoing debate.

Purpose of the Study:

  • To detail the indications and mechanism of action for ibuprofen in pediatric care.
  • To provide an overview of ibuprofen's pharmacokinetic properties.
  • To emphasize key clinical practice messages regarding ibuprofen use in children.

Main Methods:

  • Literature review of ibuprofen's pharmacological and clinical data.
  • Analysis of current guidelines and controversies in pediatric fever management.
  • Pharmacokinetic profiling of oral ibuprofen formulations.

Main Results:

  • Fever is a natural response to infection and may not require routine treatment unless the child is symptomatic or distressed.
  • Combined treatment with paracetamol and ibuprofen is common but likely offers no additional benefit.
  • Understanding ibuprofen's indications, action, and pharmacokinetics is crucial for appropriate clinical use.

Conclusions:

  • Ibuprofen is a significant NSAID in pediatrics, but its use for fever requires careful consideration.
  • Routine treatment of fever with ibuprofen, especially in combination with paracetamol, is questionable.
  • This article provides essential information for optimizing ibuprofen's clinical application in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K